Xcout IntelSign inSubscribe

CONTROL BIONICS LIMITED

Health Care Equipment & ServicesCremorne, Australia

Operating in Australia and North America, Control Bionics Limited and its subsidiaries specialize in the innovation, development, and market introduction of sophisticated assistive communication technologies. The company's offerings include the NeuroNode Trilogy and NeuroNode3 systems, which empower individuals facing speech and mobility challenges to control computers for speech generation, electronic correspondence, leisure activities, and remote operation of other devices. Control Bionics also provides Cosmos Connect, a versatile interface capable of managing diverse equipment like wheelchairs, robotic dining aids, and gaming consoles. Additionally, they offer Uno Touch, a dedicated speech-generating device, alongside various other sensors for a broad spectrum of uses. Founded in 2005, the entity was initially named Control Bionics Holdings Pty Limited before rebranding as Control Bionics Limited in September 2020. The company's base of operations is situated in Camberwell, Australia.

Subscribe to see CONTROL BIONICS LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

CONTROL BIONICS LIMITED at a glance

CONTROL BIONICS LIMITED is a health care equipment & services company headquartered in Cremorne, Australia. It has raised at least $4.8M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round, Series A, raised $3.8M in January 2026. Xcout tracks 11 named people at CONTROL BIONICS LIMITED, including Stephen D. Lebovitz (Chief Executive Officer & Director).

Industry
Health Care Equipment & Services
Headquarters
Cremorne, Australia
Raised, rounds on record
$4.8M

CONTROL BIONICS LIMITED leadership

  • Stephen D. LebovitzChief Executive Officer & Director
  • Michael I. LebovitzPresident
  • Kathryn A. ReinsmidtExecutive Vice President & Chief Operating Officer
  • Benjamin W. JaenickeExecutive Vice President, Treasurer & Chief Financial Officer
  • Shannon BoothroydChief Financial Officer
  • Jeffery V. CurryChief Legal Officer & Secretary

5 more named people on record for CONTROL BIONICS LIMITED, with roles, board committees and tenure — see the full roster →

CONTROL BIONICS LIMITED funding rounds

At least $4.8M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:

DateRoundAmountInvestors
Series A$3.8M1 named
Post IPOUndisclosed1 named
—$1M1 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

CONTROL BIONICS LIMITED competitors

A few of CONTROL BIONICS LIMITED's closest competitors — see the full list of competitors and alternatives →

COMPUMEDICS LIMITEDHealth Care Equipment & ServicesAbbotsford, Australia
69% match

Compumedics Limited is a global medical technology enterprise engaged in the full lifecycle of designing, producing, marketing, and distributing advanced diagnostic medical devices. Its market reach extends across Australia, the Asia Pacific region, the Americas, Europe, and the Middle East. The company's product portfolio is primarily focused on solutions for sleep and neurological disorders. For sleep diagnostics, offerings include sophisticated PSG:EEG amplification systems like the Grael 4K, portable recording units such as the Somté PSG and Siesta 802, wearable monitoring devices like Somfit/Somfit Pro, and transcutaneous monitors (e.g., TCM5 FLEX). In the field of neurology, Compumedics supplies devices like the ONsight A.V.S. for home ambulatory studies, a variety of EEG amplifiers (e.g., Grael 4K-EEG, Grael LT EEG), comprehensive long-term EEG monitoring systems (Neuvo 64-512 Channel LTM), and specialized EMG/EP systems (including Xegis Forte and Xegis G:NEO). Complementing its hardware, the company develops an extensive range of software, featuring the Profusion Sleep and EEG platforms, Profusion neXus 360 (a web-based system for patient data and lab management), a Multi-Modal Neuroimaging Suite, and workflow optimization tools like Profusion neXus Laboratory Management and Scheduler. Other software offerings include HD Digital Video integration and various specialized applications. Furthermore, Compumedics provides magnetoencephalography systems, cutting-edge brain research technologies, services for pharmaceutical clinical trials and research, as well as a diverse array of accessories and consumables crucial for diagnostic and research endeavors. Established in 1987, Compumedics Limited is based in Abbotsford, Australia, and functions as a subsidiary of D & DJ Burton Holdings Pty Ltd.

Valuation—
Employees—
COMPUMEDICS LIMITED competitors & alternatives →

Get CONTROL BIONICS LIMITED's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

CONTROL BIONICS LIMITED — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on CONTROL BIONICS LIMITED in Xcout Intel

  • 11 named people with titles, LinkedIn and board committees
  • 3 funding rounds with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →